Feeder-free differentiation of cells exhibiting characteristics of corneal endothelium from human induced pluripotent stem cells

The purpose of this study was to devise a strategy for the derivation of corneal endothelial cells (CEnCs) from adult fibroblast-derived induced pluripotent stem cells (iPSCs). IPSCs were generated from an adult human with normal ocular history via expression of , , and Neural crest cells (NCCs) wer...

Full description

Saved in:
Bibliographic Details
Published inBiology open Vol. 7; no. 5; p. bio032102
Main Authors Wagoner, Michael D, Bohrer, Laura R, Aldrich, Benjamin T, Greiner, Mark A, Mullins, Robert F, Worthington, Kristan S, Tucker, Budd A, Wiley, Luke A
Format Journal Article
LanguageEnglish
Published England The Company of Biologists Ltd 2018
The Company of Biologists
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to devise a strategy for the derivation of corneal endothelial cells (CEnCs) from adult fibroblast-derived induced pluripotent stem cells (iPSCs). IPSCs were generated from an adult human with normal ocular history via expression of , , and Neural crest cells (NCCs) were differentiated from iPSCs via addition of CHIR99021 and SB4315542. NCCs were driven toward a CEnC fate via addition of B27, PDGF-BB and DKK-2 to CEnC media. Differentiation of NCCs and CEnCs was evaluated via rt-PCR, morphological and immunocytochemical analysis. At 17 days post-NCC induction, there were notable changes in cell morphology and upregulation of the neural crest lineage transcripts , , , and and the proteins p75/NGFR and SOX10. Exposure of NCCs to B27, PDGF-BB and DKK-2 induced a shift in morphology from a spindle-shaped neural phenotype to a tightly-packed hexagonal appearance and increased expression of the transcripts , , , and and the proteins ZO-1, N-Cad, AQP-1 and Na /K ATPase. Replacement of NCC media with CEnC media on day 3, 5 or 8 reduced the differentiation time needed to yield CEnCs. IPSC-derived CEnCs could be used for evaluation of cornea endothelial disease pathophysiology and for testing of novel therapeutics.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2046-6390
2046-6390
DOI:10.1242/bio.032102